It's hard to admit that you're stupid.

You could turn $400,000 into $20,000 and still walk away without that self-awareness.

But when one young trader saw such a $380,000 loss on a single call option, it taught him a valuable lesson. He wrote an article for Vice in which he called himself stupid 10 times.

This wasn't even a story of complete stupidity...

Sure, this anonymous trader gambled on "meme stocks" like AMC Entertainment (AMC). Like many young people, he got sucked in by the pandemic's bull market.

But those were the trades where he made money. He emerged from a series of speculative bets having turned $5,000 into $50,000. He was ready to start playing it safe.

That's a smart instinct. But his execution was terrible.

This trader found one good investment thesis. Then he put everything he had into it: the $50,000 he'd made from his previous trading, plus all the savings he'd built up by working a good job and spending conservatively.

The company he pegged all his wealth to was Alibaba (BABA), the e-commerce giant that's like China's version of Amazon. He did some research. This was a stable, wildly successful blue-chip company. Yet its share price ($245) was down more than 25% from its peak.

The company was still making tons of money, pushing down its price-to-earnings ratio. Analysts he found online were confidently calling Alibaba a buy.

He decided to buy BABA $200 calls. If he was right and shares turned around, he'd make a fortune. If he was wrong... well, how far could this great company fall?

He put all his available cash into the trade. Alibaba kept falling. And as he earned more money, he put that cash in, too – another $100,000. He couldn't even pay his $900 rent until his next paycheck came in.

And Alibaba still kept falling. He eventually sold when his $400,000 investment in BABA calls was down to $20,000... a 95% loss. And since he put on his trade, the company's shares are down more than 50%.

The problem wasn't his investment thesis. He was right that Alibaba was a solid company at a good price. We even traded Alibaba several times in my former Advanced Options service between 2019 and 2021.

In hindsight, he realizes his error...

I should have listened to [my mom]. She told me to diversify a little. Don't go all in on one. But I felt like, because she told me not to do it so many times, I actually had to.

As his situation illustrates, everyone and their mother knows you need to diversify. This isn't an insight. It's a platitude or a hand wave, a way to prove that you considered the risks of an investment. It's an admonition akin to "Eat your vegetables"... acknowledging the wiser action without changing your behavior.

That's partly because diversification is a bit boring – it's more fun to go for the big score.

But it's also because diversification is difficult to implement... Sure, putting all your liquid assets into a single option trade is an extreme example. But diversifying properly involves understanding correlations that vary across time between assets with shifting categorizations. This is an area that human minds – even those of accomplished statisticians – can't fully understand.

Do you diversify across stocks and bonds? Growth and value? Cyclical and acyclical? Of course, you can diversify by sector, industry, size, and other features as well.

So telling someone to diversify isn't really like saying, "Eat your vegetables." It's more like telling them to eat healthy. Sure, we'd all like to... But how?

The unsexy answer is that you need to keep slogging away and try to understand your investments.

But when you're competing against the unlimited resources of Wall Street pros, where do you even start?

Well, five years ago, my company hired a man fresh off 20 years at arguably some of the most successful hedge funds on the planet.

He helped manage hundreds of millions in capital every day... structured every trade so the payoff potential far outweighed the risk... did boots-on-the-ground research in upwards of 20 countries... and monitored foreign markets in the middle of the night...

But then he walked away from Wall Street.

That's good news for you.

His brilliant approach is not based on any individual sector or market condition, but on decades of making money for billionaires in a win-or-go-home environment. And last Wednesday, he shared this approach with ordinary folks for the first time ever.

It begins – every time – with looking where 90% of market participants simply aren't.

And then he follows the exact "scripts" he knows from his decades on Wall Street that could lead to multibagger gains in a few short years.

If you missed it, catch the replay – for free – here.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
November 3, 2025

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David Eifrig
Dr. David Eifrig
Editor

Dr. Eifrig has one of the most remarkable resumes of anyone we know in this industry. After receiving his BA from the Carleton College in Minnesota, he went on to earn an MBA from Northwestern University’s Kellogg School of Management, graduating on the Dean’s List with a double major in finance and international business.

From there, Dr. Eifrig went to work as an elite derivatives trader at the investment bank Goldman Sachs. He spent a decade on Wall Street with several major institutions, including Chase Manhattan and Yamaichi (then known as the “Goldman Sachs of Japan”).

That’s when Dr. Eifrig’s career took an unconventional turn. Sick of the greed and hypocrisy of Wall Street... he quit his senior vice president position to become a doctor. He graduated from Columbia University’s post-baccalaureate pre-medicine program and eventually earned his MD with clinical honors from the University of North Carolina at Chapel Hill. While at med school, he was elected president of his class and admitted to the Order of the Golden Fleece (considered the highest honor given at UNC-Chapel Hill).

Dr. Eifrig also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotech company, Mirus, that was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine’s many conflicts, Dr. Eifrig began to look for ways he could talk directly with individuals and use his background to show them how to take control of their health and wealth. In 2008, he joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams, and Income Intelligence, the most comprehensive monthly review we know of the universe of income investments.

He is also the author of five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He also owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California.

Back to Top